Silencing of G0/G1 switch gene 2 in cutaneous squamous cell carcinoma.

Yoshimasa Nobeyama,Hidemi Nakagawa,Yoshinori Watanabe,Magdalena Grce

doi:10.1371/journal.pone.0187047

Yoshimasa Nobeyama, Hidemi Nakagawa + Show 2 more

Open Access

https://doi.org/10.1371/journal.pone.0187047

Copy DOI

Journal: PloS one	Publication Date: Oct 26, 2017
Citations: 15	License type: CC BY 4.0

Affiliation: Jikei University School of Medicine

Abstract

BackgroundMethylation of a CpG island (CGI; a dense cluster of CpGs) located in the 5' region of a gene suppresses that gene's transcription. The expression of G0/G1 switch gene 2 (G0S2) is potentially associated with tumorigenesis. The aim of this study is to elucidate the methylation status of the CGI located in the 5' region of G0S2 (hereinafter called 5' G0S2 CGI) in cutaneous squamous cell carcinoma (SCC).MethodsQuantitative real-time methylation-specific PCR (RT-MSP) and bisulfite sequencing were performed to evaluate the methylation statuses of cutaneous SCC and normal epithelial cell samples. Quantitative real-time reverse transcription-PCR was performed to evaluate RNA expression levels. Immunohistochemical analysis was performed to detect protein expression.ResultsG0S2 was suppressed in the five SCC cell lines with 5' G0S2 CGI methylation levels of nearly 100.0% and was expressed in the two normal cultured keratinocytes with methylation levels of almost 0.0%. G0S2 was re-expressed in SCC cell lines treated with a demethylating agent. The in vivo methylation levels of 5' G0S2 CGI as determined by RT-MSP varied widely (0.0% to 77.7%) in 17 cutaneous SCC samples and narrowly (0.1% to 7.3%) in 6 normal epidermis samples. Nine cutaneous SCC samples exhibited higher methylation levels than the highest methylation level (7.3%) of the 6 normal epidermis samples. Bisulfite sequencing showed dense methylated CpG sites within 5' G0S2 CGI in these highly methylated cutaneous SCC samples. The methylation levels of the cutaneous SCC samples did not correlate with any clinical parameters investigated or with histopathological grading.ConclusionsG0S2 is silenced by aberrant DNA methylation in a subset of cutaneous SCCs.

Highlights

DNA methylation is a DNA modification resulting from the covalent binding of a methyl group to a DNA nucleotide, such as the cytosine of a CpG dinucleotide where a 5’ cytosine is adjacent to a 3’ guanine [1,2]
G0S2 was suppressed in the five squamous cell carcinoma (SCC) cell lines with 5’ G0S2 CpG island (CGI) methylation levels of nearly 100.0% and was expressed in the two normal cultured keratinocytes with methylation levels of almost 0.0%
reverse transcription-PCR (RT-PCR) showed G0S2 expression in normal keratinocytes, and real-time methylation-specific PCR (RT-MSP) detected a substantial amount of G0S2 CGI unmethylated at the 5’ region (Fig 2A)

Summary

Introduction

DNA methylation is a DNA modification resulting from the covalent binding of a methyl group to a DNA nucleotide, such as the cytosine of a CpG dinucleotide where a 5’ cytosine is adjacent to a 3’ guanine [1,2]. CpG islands (CGIs) are dense clusters of CpGs that are often located in the 5’ regions of genes. Methylation of a CGI located in the 5’ region of a gene suppresses the transcription of that gene [4]. The CGIs located in the 5’ regions of most genes are unmethylated, and these genes can be expressed [4]. In malignant cells, the CGIs located in the 5’ regions of a number of genes, including tumor-suppressor genes, may be methylated, and the transcription of these genes is suppressed [4,5]. Methylation of a CpG island (CGI; a dense cluster of CpGs) located in the 5’ region of a gene suppresses that gene’s transcription.

Objectives

Methods

Results

Conclusion